Abstract
Malignant pleural effusion (MPE) results from primary mesothelioma or the spreading of metastatic cancer. Both talc pleurodesis (TP) and indwelling pleural catheter (IPC) improve MPE symptoms. We performed a meta-analysis of randomized controlled trials to compare the efficacy of TP with that of IPC in patients with MPE. PubMed, EMBASE, Cochrane Library, and ClinicalTrials.gov databases were searched for studies published before February 2020. Individual effect sizes were standardized, and a meta-analysis was conducted to calculate a pooled effect size by using random effects models. In total, 4 trials with 500 patients were reviewed. Difference in pleurodesis success rate and change in dyspnea scores at 4 and 6 weeks between MPE patients treated with IPC and those treated with TP for pleurodesis were nonsignificant. The number of hospital inpatient days was significantly lower among patients who were treated with IPC (weight mean difference: 2.19; 95% confidence interval 0.70–3.67) than among those who were treated with TP. No significant difference was shown in adverse event profile between patients treated with IPC and those treated with TP for pleurodesis. In conclusion, both TP and IPC are equally effective in treating patients with MPE. The number of hospitalization days was significantly lower for patients who were treated with IPC, but the magnitude of the difference is of uncertain clinical importance.
Similar content being viewed by others
Abbreviations
- CI:
-
Confidence interval
- EQ-5D-5 L:
-
EuroQoL Group 5-Dimensions 5-Level Questionnaire
- IPC:
-
Indwelling pleural catheter
- MBS:
-
Modified Borg Scale
- MeSH:
-
Medical subject headings
- MPE:
-
Malignant pleural effusion
- QLQ-C30:
-
quality of life questionnaire-core 30
- QoL:
-
Quality of life
- RCT:
-
Randomized controlled trials
- RoB:
-
Risk of bias
- RR:
-
Risk ratios
- TP:
-
Talc pleurodesis
- WMD:
-
Weighted mean difference
References
Clive AO, Jones HE, Bhatnagar R, Preston NJ, Maskell N (2016) Interventions for the management of malignant pleural effusion: a network meta-analysis. Cochrane Database Syst Rev 5:CD010529. https://doi.org/10.1002/14651858.CD010529.pub2
Bhatnagar R, Keenan EK, Morley AJ, Kahan BC, Stanton AE, Haris M, Harrison RN, Mustafa RA, Bishop LJ, Ahmed L, West A, Holme J, Evison M, Munavvar M, Sivasothy P, Herre J, Cooper D, Roberts M, Guhan A, Hooper C, Walters J, Saba TS, Chakrabarti B, Gunatilake S, Psallidas I, Walker SP, Bibby AC, Smith S, Stadon LJ, Zahan-Evans NJ, Lee YCG, Harvey JE, Rahman NM, Miller RF, Maskell NA (2018) Outpatient talc administration by indwelling pleural catheter for malignant effusion. N Engl J Med 378:1313–1322. https://doi.org/10.1056/NEJMoa1716883
Porcel JM, Sole C, Salud A, Bielsa S (2017) Prognosis of cancer with synchronous or metachronous malignant pleural effusion. Lung 195:775–779. https://doi.org/10.1007/s00408-017-0050-1
Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ, BTS Pleural Disease Guideline Group (2010) Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorax 65 (Suppl 2):ii32–i40. https://doi.org/10.1136/thx.2010.136994
Xia H, Wang XJ, Zhou Q, Shi HZ, Tong ZH (2014) Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis. PLoS ONE 9:e87060. https://doi.org/10.1371/journal.pone.0087060
Porcel JM, Lui MM, Lerner AD, Davies HE, Feller-Kopman D, Lee YC (2017) Comparing approaches to the management of malignant pleural effusions. Expert Rev Respir Med 11:273–284. https://doi.org/10.1080/17476348.2017.1300532
Davies HE, Mishra EK, Kahan BC, Wrightson JM, Stanton AE, Guhan A, Davies CW, Grayez J, Harrison R, Prasad A, Crosthwaite N, Lee YC, Davies RJ, Miller RF, Rahman NM (2012) Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion. JAMA 307:2383–2389. https://doi.org/10.1001/jama.2012.5535
Thomas R, Fysh ETH, Smith NA, Lee P, Kwan BCH, Yap E, Horwood FC, Piccolo F, Lam DCL, Garske LA, Shrestha R, Kosky C, Read CA, Murray K, Lee YCG (2017) Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE Randomized Clinical Trial. JAMA 318:1903–1912. https://doi.org/10.1001/jama.2017.17426
Boshuizen RC, Vd Noort V, Burgers JA, Herder GJM, Hashemi SMS, Hiltermann TJN, Kunst PW, Stigt JA, van den Heuvel MM (2017) A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14). Lung Cancer 108:9–14. https://doi.org/10.1016/j.lungcan.2017.01.019
Sørensen PG, Svendsen TL, Enk B (1984) Treatment of malignant pleural effusion with drainage with and without instillation of talc. Eur J Respir Dis 65:131–135
Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. http://www.cochrane-handbook.org
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–e34. https://doi.org/10.1016/j.jclinepi.2009.06.006
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727–1736. https://doi.org/10.1007/s11136-011-9903-x
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376. https://doi.org/10.1093/jnci/85.5.365
Gawron G, Gabrys J, Barczyk A (2013) Talc slurry pleurodesis via chest tube in department of pulmonology: a 24-case study. Pneumonol Alergol Pol 81:439–447
Hunt BM, Farivar AS, Vallières E, Louie BE, Aye RW, Flores EE, Gorden JA (2012) Thoracoscopic talc versus tunneled pleural catheters for palliation of malignant pleural effusions. Ann Thorac Surg 94:1053–1057. https://doi.org/10.1016/j.athoracsur.2012.01.103
Fysh ETH, Waterer GW, Kendall PA, Bremner PR, Dina S, Geelhoed E, McCarney K, Morey S, Millward M, Musk AWB, Lee YCG (2012) Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. Chest 142:394–400. https://doi.org/10.1378/chest.11-2657
Asciak R, Hallifax RJ, Mercer RM, Hassan M, Wigston C, Wrightson JM, Psallidas I, Rahman NM (2018) The hospital and patient burden of indwelling pleural catheters: a retrospective case series of 210 indwelling pleural catheter insertions. Respiration 97:70–77. https://doi.org/10.1159/000491934
Srour N, Amjadi K, Forster AJ, Aaron S (2013) Management of malignant pleural effusion with indwelling pleural catheters or talc pleurodesis. Can Respir J 20:106–110. https://doi.org/10.1155/2013/842768
Liou DZ, Serna-Gallegos D, Chan JL, Borgella J, Akhmerov S, Soukiasian HJ (2016) Survival difference in patients with malignant pleural effusions treated with pleural catheter or talc pleurodesis. Am Surg 82:995–999
Van Meter ME, McKee KY, Kohlwes RJ (2011) Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med 26:70–76. https://doi.org/10.1007/s11606-010-1472-0
Muruganandan S, Azzopardi M, Fitzgerald DB, Shrestha R, Kwan BCH, Lam DCL, De Chaneet CC, Rashid Ali MRS, Yap E, Tobin CL, Garske LA, Nguyen PT, Stanley C, Popowicz ND, Kosky C, Thomas R, Read CA, Budgeon CA, Feller-Kopman D, Maskell NA, Murray K, Lee YCG (2018) Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial. Lancet Respir Med 6:671–680. https://doi.org/10.1016/S2213-2600(18)30288-1
Acknowledgements
We thank Mr. Eugene, Chun-Chit Cheng for assistance with data collection, and Wallace Academic Editing for edition of the manuscript.
Funding
This research received no specific Grant from any funding agency in the public, commercial, or not-for-profit sector.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors Maggie Yeung, El-Wui Loh, Tung-Yu Tiong, and Ka-Wai Tam have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yeung, M., Loh, EW., Tiong, TY. et al. Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis. Clin Exp Metastasis 37, 541–549 (2020). https://doi.org/10.1007/s10585-020-10042-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-020-10042-2